TSE:ATS

ATS Automation Tooling Systems (ATS.TO)

37.51
-1.75 (4.46%)
as of Jun 5, 2026, 8:00:00 pm Market Open.
211 watching
0
Investor Insights
star iconJun 6, 2026, 12:00 am

This summary was created by AI, based on 6 opinions in the last 12 months.

ATS Automation Tooling Systems (ATS-T) has received generally positive reviews from various experts, highlighting its resilience and strong market positioning despite some recent volatility. The company reported revenue that surpassed expectations, although bookings have started to soften. Analysts note a strategic shift towards higher-quality businesses, which may sacrifice short-term growth for long-term stability. There is a consensus that ATS is well-placed to benefit from ongoing trends like reshoring and modernization of global manufacturing, with most reviews indicating a potential upside in share prices within a range of 10% to 25%. The overall outlook remains optimistic, with strong fundamentals and a healthy project pipeline bolstering confidence among analysts.

consensus icon
Consensus
Positive
valuation icon
Valuation
Undervalued
review icon
Similar
Rohm, ROHM
PAST TOP PICK
(A Top Pick Feb 27/23, Up 7%)

Automation is here to stay. They have great experience and lots of opportunities.

BUY

Strong business with automation business. Good for long term investors. Current share price a good place to buy. Expecting 29% growth rate for the next few years. Good time to buy. 

BUY ON WEAKNESS

Likes it, but always looks so expensive. Fairly good recurring revenue. Margins have held up well. Not bad for growth. PE of 35x, price to book of 3.5x, expensive.

BUY ON WEAKNESS
Trevor Rose’s Insights - Trevor’s most-liked answers from 5i Research

ATS share price has been under pressure recently along with the broad market, as the market sentiment factors in the scenario that interest rates may stay higher for longer, which not only impacts growth in orders for industrial space such as ATS, but also the valuation multiple that investors are willing to pay for high-growth name such as ATS. Having said that, ATS’s valuation is still attractive, in our view. ATS has been well-run over the years, and it has a decent backlog and fairly visible growth. Its recent acquisitions also look good. 'Future' orders might be impacted in a recession, but we would say that pretty much anytime.
Unlock Premium - Try 5i Free

Unspecified

It designs, makes and installs automatic manufacturing systems globally and has a huge backlog. It is well known in the life sciences field which is a big part of its business. It also has a specialized battery division, is involved with nuclear reactors, consumer products, transportation, etc. It is M&A driven and makes selective acquisitions.

BUY

One of the best performers this year. Keeps announcing more contracts, backlog's growing. Focused on life sciences and EV assembly plants. Picking high-growth niche areas. Not cheap, but the sky's the limit.

BUY ON WEAKNESS

Pullbacks don't last long on this stock. Sweet spot. High-growth areas such as battery production and health sciences, where they provide turnkey solutions. Not cheap. Buy it on a dip and put it away.

HOLD
Trevor Rose’s Insights - Trevor’s most-liked answers from 5i Research.

ATS is an industry-leading automation solutions provider to many of the world's most successful companies. It uses its extensive knowledge base and global capabilities in custom automation, repeat automation, automation products, and value-added services to address the sophisticated manufacturing automation systems and service needs of multinational customers in markets such as life sciences, food & beverage, transportation, consumer products, and energy. Founded in 1978, ATS employs over 6,000 people at more than 50 manufacturing facilities and over 75 offices in North America, Europe, Southeast Asia, and China.Results for the 2nd quarter ended October 2, 2022, were not spectacular. While revenues at $588.9 million were up 12.8 % over the comparable prior year period, net earnings at $29.5 million were basically flat due largely to higher finance costs ($6.2 million, to finance the acquisition of SP) and income taxes ($3.1 million). Adjusted EBITDA at $88.8 million was up 6.6%. Cash at the end of the quarter amounted to $95.2 million after utilizing $44.7 million during the period primarily due to changes in non-cash working capital. The debt-equity ratio is 1.26. With a large backlog ($1.8 billion), established operations and markets as well as experienced management ATS should find opportunities ahead.
Unlock Premium - Try 5i Free

BUY

Great chart. 
Good time to buy.
Would suggest buying.

TOP PICK

Machinery companies are doing well and automation is here to stay. Has sold equipment to companies like Amazon. Its business is also in health care, consumer products and now EV. It also benefits from the re-shoring of manufacturing in North America.

(Analysts’ price target is $64.67)
BUY ON WEAKNESS

Good Canadian company.
Will perform well over the long term.
Has out performed the market the past few years.
Automation demand growing. 
Multiples a little high, but deserves success.

DON'T BUY
Not recession-tested yet. Earnings excellent quarter after quarter. Theme of reshoring is powerful and will benefit. Price to growth looks good. Only issue is recession or supply chain inflation. Better opportunities out there.
BUY
Is well-positioned as wages keep rising and there are staffing shortages. Has a sound balance sheet. Has enjoyed a recent upgrade. Good for the long term, and defensive in the short term.
HOLD
A core position. Management executes exceptionally well. Record backlog, which should support margins and earnings for the next few quarters. Cheap multiple compared to US peers. In the sweet spot.
HOLD

Trevor Rose’s Insights - Trevor’s most-liked answers from 5i Research. Long-term demand for automation. Operates in a cyclical business. Heavier exposure to non-cyclical segments. Diverse supply base. Unlock Premium - Try 5i Free

Showing 16 to 30 of 203 entries